Judy Chou

Company: AltruBio

Job title: President and Chief Executive Officer

Seminars:

Development of a Novel Immune Checkpoint Enhancer as a Potential Therapeutic Medicine for Ulcerative Colitis 11:30 am

An in-depth exploration for the capacity of emerging approaches regarding non-immune cells to revolutionize our understanding of IBD Exploring the capacity for precision medicine strategies target these unconventional players to open new avenues for IBD treatment innovationRead more

day: Day Two